These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1576670)

  • 1. Lobenzarit disodium (CCA) inhibits in vitro immunoglobulin production via direct interaction with B lymphocytes.
    Takeda Y; Urakawa K; Sakamoto A; Nakano T; Sugawara Y; Ohsugi Y; Morita M; Kasahara T
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):177-81. PubMed ID: 1576670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of B cell function by lobenzarit, a novel disease-modifying antirheumatic drug.
    Hirohata S; Shinohara S; Inoue T; Miyamoto T; Lipsky PE
    Arthritis Rheum; 1992 Feb; 35(2):168-75. PubMed ID: 1734906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of in vitro anti-DNA antibody production by a novel disease modifying anti-rheumatic drug, Lobenzarit.
    Hirohata S
    Clin Exp Rheumatol; 1992; 10(4):357-63. PubMed ID: 1356678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopharmacological study of CCA (Lobenzarit disodium), an anti-arthritis agent--I. Abrogation of IL 1 secretion by LPS-stimulated human monocytes and induction of gamma-interferon production with CCA.
    Fujimoto M; Sugawara I; Kimoto M; Ishizaka S; Tsujii T
    Int J Immunopharmacol; 1986; 8(3):323-8. PubMed ID: 3089953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunomodulating anti-rheumatic drug, lobenzarit disodium (CCA): inhibition of polyclonal B-cell activation and prevention of autoimmune disease in MRL/Mp-lpr/lpr mice.
    Mihara M; Nakano T; Ohsugi Y
    Clin Immunol Immunopathol; 1987 Dec; 45(3):366-74. PubMed ID: 3500002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lobenzarit disodium on human endothelial cells. Lobenzarit disodium inhibits proliferative response, HLA-DR antigen expression, and T cell adherence toward endothelial cells.
    Kawakami A; Eguchi K; Ueki Y; Migita K; Ida H; Nakao H; Kurata A; Fukuda T; Ishimaru T; Kurouji K
    Arthritis Rheum; 1991 Mar; 34(3):296-303. PubMed ID: 1900689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclosporine and rapamycin on immunoglobulin production by preactivated human B cells.
    Kim HS; Raskova J; Degiannis D; Raska K
    Clin Exp Immunol; 1994 Jun; 96(3):508-12. PubMed ID: 8004821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New immunomodulator lobenzarit disodium (CCA): activation of IgE class-specific suppressor T lymphocytes and regulation of IgE antibody response enhanced by sublethal X-irradiation in SJL/J mice.
    Yamashita Y; Nakano T; Ohsugi Y
    Int Arch Allergy Appl Immunol; 1987; 83(3):296-302. PubMed ID: 2954916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of lobenzarit disodium (CCA) on B cell differentiation to antibody secreting cells].
    Imai F; Suzuki T; Ishibashi T; Katagiri T; Hara K
    Arerugi; 1989 Jan; 38(1):36-40. PubMed ID: 2662944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-oxidative profile of lobenzarit disodium (CCA).
    Cynshi O; Saitoh M; Cynshi F; Tanemura M; Hata S; Nakano M
    Biochem Pharmacol; 1990 Nov; 40(9):2117-22. PubMed ID: 2242038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alleviation of depressed immunity caused by restraint-stress, by the immunomodulator, lobenzarit disodium (disodium 4-chloro-2,2'-iminodibenzoate).
    Komori T; Nakano T; Ohsugi Y
    Int J Immunopharmacol; 1987; 9(4):433-41. PubMed ID: 3623769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel antiarthritic agent, CCA (lobenzarit disodium), and the role of thymus-derived lymphocytes in the inhibition of rat adjuvant arthritis.
    Ohsugi Y; Nakano T; Hata S
    Immunopharmacology; 1983 Jun; 6(1):15-21. PubMed ID: 6603446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCA (disodium 4-chloro-2,2'-iminodibenzoate) inhibits progression of human T cell proliferation triggered by PHA.
    Katagiri K; Nakano T; Sugawara Y; Ichikawa Y; Yoshida T
    Clin Immunol Immunopathol; 1990 Sep; 56(3):384-92. PubMed ID: 2118015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of the antirheumatic agents N-(2-carboxyphenyl)-4-chloroanthranilic acid disodium (CCA) and D-penicillamine on the NK and ADCC activities and interferon production of lymphocytes.
    Ohara M; Igarashi S; Kobashi C; Nanamiya M; Yoshida H; Kasukawa R
    J Immunopharmacol; 1984; 6(3):163-72. PubMed ID: 6208286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activation of hepatic glutathione reductase from mice by lobenzarit disodium.
    Armesto J; Frutos N; Gonzalez R; Pascual C
    Agents Actions; 1993 May; 39(1-2):69-71. PubMed ID: 8285143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells.
    Kishimoto C; Takada H; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S
    Cardiovasc Res; 1993 Feb; 27(2):243-8. PubMed ID: 8386064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
    Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
    Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin.
    Aagaard-Tillery KM; Jelinek DF
    Cell Immunol; 1994 Jul; 156(2):493-507. PubMed ID: 7517796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of interferon-alpha on immunoglobulin synthesis by human B cells.
    Peters M; Ambrus JL; Zheleznyak A; Walling D; Hoofnagle JH
    J Immunol; 1986 Nov; 137(10):3153-7. PubMed ID: 3021846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ozone on immunoglobulin production by human B cells in vitro.
    Becker S; Quay J; Koren HS
    J Toxicol Environ Health; 1991 Nov; 34(3):353-66. PubMed ID: 1834858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.